Suppr超能文献

相似文献

2
Serum pepsinogen and gastric cancer screening.
Intern Med. 2007;46(6):261-6. doi: 10.2169/internalmedicine.46.6181. Epub 2007 Mar 15.
4
Validation of the pepsinogen test method for gastric cancer screening using a follow-up study.
Gastric Cancer. 2009;12(3):158-63. doi: 10.1007/s10120-009-0522-y. Epub 2009 Nov 5.
6
Usefulness of gastric cancer screening using the serum pepsinogen test method.
Am J Gastroenterol. 2003 Apr;98(4):735-9. doi: 10.1111/j.1572-0241.2003.07410.x.
8
Cancer high-risk subjects identified by serum pepsinogen tests: outcomes after 10-year follow-up in asymptomatic middle-aged males.
Cancer Epidemiol Biomarkers Prev. 2008 Apr;17(4):838-45. doi: 10.1158/1055-9965.EPI-07-2762.
9
Accuracy of screening for gastric cancer using serum pepsinogen concentrations.
Gut. 1999 May;44(5):693-7. doi: 10.1136/gut.44.5.693.
10
Comparison of serum trefoil factor 3 with the pepsinogen test for the screening of diffuse-type gastric cancer.
Clin Exp Med. 2017 Aug;17(3):403-410. doi: 10.1007/s10238-016-0426-1. Epub 2016 May 6.

引用本文的文献

2
Global progress and future prospects of early gastric cancer screening.
J Cancer. 2024 Apr 8;15(10):3045-3064. doi: 10.7150/jca.95311. eCollection 2024.
3
Mitochondrial DNA Copy Number Variations and Serum Pepsinogen Levels for Risk Assessment in Gastric Cancer.
Iran Biomed J. 2021 Sep 1;25(5):323-33. doi: 10.52547/ibj.25.5.323. Epub 2021 Aug 22.
4
Geographic and Socioeconomic Disparity of Gastric Cancer Patients in Canada.
Curr Oncol. 2021 May 28;28(3):2052-2064. doi: 10.3390/curroncol28030190.
6
Insights into the evaluation and management of dyspepsia: recent developments and new guidelines.
Therap Adv Gastroenterol. 2018 Oct 30;11:1756284818805597. doi: 10.1177/1756284818805597. eCollection 2018.
7
Decreased LIPF expression is correlated with DGKA and predicts poor outcome of gastric cancer.
Oncol Rep. 2016 Oct;36(4):1852-60. doi: 10.3892/or.2016.4989. Epub 2016 Aug 1.
8
Downregulation of human Wnt3 in gastric cancer suppresses cell proliferation and induces apoptosis.
Onco Targets Ther. 2016 Jun 27;9:3849-60. doi: 10.2147/OTT.S101782. eCollection 2016.
10
Current issues and future perspectives of gastric cancer screening.
World J Gastroenterol. 2014 Oct 14;20(38):13767-74. doi: 10.3748/wjg.v20.i38.13767.

本文引用的文献

2
Usefulness of gastric cancer screening using the serum pepsinogen test method.
Am J Gastroenterol. 2003 Apr;98(4):735-9. doi: 10.1111/j.1572-0241.2003.07410.x.
4
The epidemiology of gastric cancer.
Semin Radiat Oncol. 2002 Apr;12(2):111-27. doi: 10.1053/srao.30814.
6
Accuracy of screening for gastric cancer using serum pepsinogen concentrations.
Gut. 1999 May;44(5):693-7. doi: 10.1136/gut.44.5.693.
8
Sensitivity and specificity of mass screening for gastric cancer using the measurment of serum pepsinogens.
Jpn J Cancer Res. 1995 Dec;86(12):1210-5. doi: 10.1111/j.1349-7006.1995.tb03317.x.
9
Correlation between the prevalence of gastritis and gastric cancer in Japan.
Cancer Causes Control. 1993 Jan;4(1):17-20. doi: 10.1007/BF00051709.
10
Clinical application of serum pepsinogen I and II levels for mass screening to detect gastric cancer.
Jpn J Cancer Res. 1993 Oct;84(10):1086-90. doi: 10.1111/j.1349-7006.1993.tb02805.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验